Marton König

Modification of Slow Cortical Potentials in Patients with Refractory Epilepsy: A Controlled Outcome Study

Boris Kotchoubey, Ute Strehl, Carmen Uhlmann et al. · Epilepsia · 2001 · 248 citations

Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination

Marton König, Hilde Marie Torgauten, The Trung Tran et al. · JAMA Neurology · 2022 · 84 citations · Full text

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations

Marton König, Åslaug Rudjord Lorentzen, Hilde Marie Torgauten et al. · Journal of Neurology Neurosurgery & Psychiatry · 2021 · 54 citations · Full text

Is first-line single-agent mitoxantrone in the treatment ofhigh-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial

E. Heidemann, Herbert Stoeger, Rainer Souchon et al. · Annals of Oncology · 2002 · 49 citations

Breast Oncology, Oncology, Combination Chemotherapy +9

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants

Trung Tran, Eline Benno Vaage, Adi Mehta et al. · npj Vaccines · 2022 · 43 citations · Full text

Vaccination, Viral Evolution, Vaccine Development +12